loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Ice Pharma

    Client Virtual Booth
    Menu

    ICE Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    INTERMEDIATES

    SERVICES

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Chenodeoxycholic Acid (1)

    02 Cholic Acid (1)

    03 Dehydrocholic Acid (1)

    04 Deoxycholic Acid (1)

    05 Doxofylline (1)

    06 Inosine Pranobex (1)

    07 N Acetylneuraminic Acid (1)

    08 Taurine (1)

    09 Ursodeoxycholic Acid (1)

    10 Ursodoxicoltaurine (1)

    filter

    01 ICE Pharma (10)

    filter

    01 Italy (10)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Chenodeoxycholic Acid

    PDF Supplier PDF
    URL Supplier Web Content
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and inte...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    EASL Congress

    Attending

    envelop Contact Supplier

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Cholic Acid

    PDF Supplier PDF
    URL Supplier Web Content
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and inte...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    EASL Congress

    Attending

    envelop Contact Supplier

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Dehydrocholic Acid

    PDF Supplier PDF
    URL Supplier Web Content
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and inte...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    EASL Congress

    Attending

    envelop Contact Supplier

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Deoxycholic Acid

    PDF Supplier PDF
    URL Supplier Web Content
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and inte...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    EASL Congress

    Attending

    envelop Contact Supplier

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Doxofylline

    PDF Supplier PDF
    URL Supplier Web Content
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and inte...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    EASL Congress

    Attending

    envelop Contact Supplier

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Inosine Pranobex

    PDF Supplier PDF
    URL Supplier Web Content
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and inte...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    EASL Congress

    Attending

    envelop Contact Supplier

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    N Acetylneuraminic Acid

    PDF Supplier PDF
    URL Supplier Web Content
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and inte...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    EASL Congress

    Attending

    envelop Contact Supplier

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Taurine

    PDF Supplier PDF
    URL Supplier Web Content
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and inte...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    EASL Congress

    Attending

    envelop Contact Supplier

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ursodeoxycholic Acid

    PDF Supplier PDF
    URL Supplier Web Content
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and inte...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    EASL Congress

    Attending

    envelop Contact Supplier

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ursodoxicoltaurine

    PDF Supplier PDF
    URL Supplier Web Content
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and inte...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    EASL Congress

    Attending

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY